MKI67 and neoplasm: At the end of the treatment cycle, siHsp27/DSPE-KK2 significantly down-regulated Hsp27 expression in the tumor, slowing down tumor growth as also confirmed by the reduced levels of Ki67, a known marker of cell proliferation.